Kalijev Jodid Lek (Potassium Iodide)

Potassium iodide releases iodide ions that are taken up by the thyroid via the sodium‑iodide symporter. The sudden increase in iodide saturates the gland, temporarily inhibiting further iodide uptake (Wolff‑Chaikoff effect) and reducing the incorporation of radioactive iodine while supporting normal thyroid hormone synthesis.

The appropriate dose of Kalijev Jodid Lek is determined by a qualified healthcare professional based on the indication, patient age, weight, and clinical context. Prescribers follow national or institutional guidelines to set the exact regimen.

Safety data for potassium iodide in pregnancy and lactation are limited. It should be used only when clearly needed and after a risk‑benefit assessment by the prescriber. Breastfeeding mothers should discuss potential iodine transfer to the infant with their healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Kalijev Jodid Lek delivers potassium iodide, the same active ingredient found in many stable‑iodine tablets used for radiation emergencies. Compared with liquid iodide solutions, the oral tablet form offers convenient dosing, stable storage, and precise iodine content, making it suitable for stockpiling and rapid distribution.

Store Kalijev Jodid Lek at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, heat, and direct sunlight. Do not store in a refrigerator or freezer unless the label specifically advises otherwise.

Kalijev Jodid Lek is taken orally, usually with water. The tablet should be swallowed whole unless a prescriber advises otherwise. Administration can be performed by a patient, caregiver, or healthcare professional, following the dosage instructions provided by the prescribing clinician.

Serious risks include severe allergic reactions (anaphylaxis), significant thyroid dysfunction such as hypothyroidism or hyperthyroidism, and rare cases of acute kidney injury in susceptible individuals. Patients should seek immediate medical attention if they experience rash, swelling, difficulty breathing, or abrupt changes in thyroid symptoms.

Individuals with known hypersensitivity to potassium iodide or any component of the tablet should avoid use. Patients with uncontrolled thyroid disease, certain renal impairments, or those already receiving high‑dose iodide therapy should consult their healthcare provider before taking the product.